DE69603163D1 - VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2-PIPERAZIN-t-BUTYLCARBOXAMID - Google Patents

VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2-PIPERAZIN-t-BUTYLCARBOXAMID

Info

Publication number
DE69603163D1
DE69603163D1 DE69603163T DE69603163T DE69603163D1 DE 69603163 D1 DE69603163 D1 DE 69603163D1 DE 69603163 T DE69603163 T DE 69603163T DE 69603163 T DE69603163 T DE 69603163T DE 69603163 D1 DE69603163 D1 DE 69603163D1
Authority
DE
Germany
Prior art keywords
butylcarboxamide
picolyl
piperazine
protease inhibitor
hiv protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69603163T
Other languages
English (en)
Inventor
David Askin
Kan Eng
Paul Reider
Ralph Volante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69603163D1 publication Critical patent/DE69603163D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DE69603163T 1995-03-15 1996-03-11 VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2-PIPERAZIN-t-BUTYLCARBOXAMID Expired - Lifetime DE69603163D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/404,798 US5618937A (en) 1995-03-15 1995-03-15 Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide
PCT/US1996/002556 WO1996028439A1 (en) 1995-03-15 1996-03-11 PROCESS TO MAKE HIV PROTEASE INHIBITOR FROM 2(S)-4-PICOLYL-2-PIPERAZINE-t-BUTYLCARBOXAMIDE

Publications (1)

Publication Number Publication Date
DE69603163D1 true DE69603163D1 (de) 1999-08-12

Family

ID=23601087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69603163T Expired - Lifetime DE69603163D1 (de) 1995-03-15 1996-03-11 VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2-PIPERAZIN-t-BUTYLCARBOXAMID

Country Status (16)

Country Link
US (1) US5618937A (de)
EP (1) EP0815101B1 (de)
CN (1) CN1100054C (de)
AR (1) AR002712A1 (de)
AT (1) ATE181916T1 (de)
AU (1) AU5173896A (de)
BR (1) BR9607376A (de)
CZ (1) CZ292549B6 (de)
DE (1) DE69603163D1 (de)
EA (1) EA000178B1 (de)
HR (1) HRP960114B1 (de)
SK (1) SK282021B6 (de)
TW (1) TW332205B (de)
UA (1) UA49826C2 (de)
WO (1) WO1996028439A1 (de)
YU (1) YU15496A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700364A (en) * 1995-10-30 1997-12-23 Merck & Co., Inc. Electrochemical oxidation
NL1006305C2 (nl) * 1997-06-13 1998-12-15 Dsm Nv Werkwijze voor de bereiding van (1S,2R)-1-amino-2-indanol-(R,R)-tartraat methanol solvaat.
US7199240B2 (en) * 2002-12-11 2007-04-03 Merck & Co., Inc. Reductive alkylation of saturated cyclic amines
US10620330B2 (en) 2013-03-19 2020-04-14 Westerngeco L.L.C. Estimating translational data
CN110835405B (zh) * 2019-11-28 2020-09-15 安阳师范学院 用于肿瘤检测的高分子生物传感器及制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169952A (en) * 1991-07-02 1992-12-08 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5463067A (en) * 1993-07-16 1995-10-31 Merck & Co., Inc. Process for making HIV protease inhibitors
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
US5420353A (en) * 1994-03-11 1995-05-30 Merck & Co., Inc. Regiospecific process to make cis-1-amino-2-alkanol from epoxide
US5449830A (en) * 1994-03-11 1995-09-12 Marck & Co., Inc. Regiospecific processes to make CIS-1-Amino-2-Alkanol from Diol or Halohydrin

Also Published As

Publication number Publication date
CZ292549B6 (cs) 2003-10-15
CN1183779A (zh) 1998-06-03
US5618937A (en) 1997-04-08
TW332205B (en) 1998-05-21
HRP960114A2 (en) 1997-10-31
UA49826C2 (uk) 2002-10-15
YU15496A (sh) 1999-03-04
HRP960114B1 (en) 2000-02-29
SK282021B6 (sk) 2001-10-08
ATE181916T1 (de) 1999-07-15
WO1996028439A1 (en) 1996-09-19
EP0815101A1 (de) 1998-01-07
CZ286097A3 (cs) 1998-02-18
AR002712A1 (es) 1998-04-29
EP0815101B1 (de) 1999-07-07
AU5173896A (en) 1996-10-02
CN1100054C (zh) 2003-01-29
EA199700235A1 (ru) 1998-04-30
BR9607376A (pt) 1997-12-30
SK122597A3 (en) 1998-02-04
EA000178B1 (ru) 1998-12-24

Similar Documents

Publication Publication Date Title
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE69502701T3 (de) Verfahren zur herstellung von reinigungsmitteltabletten
DE69603255T2 (de) Verfahren zur modifizierung von oberflächen
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
DE69816440D1 (de) Verfahren zur herstellung von flurbiprofen-lutschtabletten
DE69618646T2 (de) Verfahren zur herstellung von peroxiden
DE69808037T2 (de) Verfahren zur herstellung von hydroperoxiden
DE69612745T2 (de) Verfahren zur herstellung von hydroxyalkylamiden
DE69628421D1 (de) Verfahren zur herstellung von tetraazacycloalkanen.
DE69615660D1 (de) Verfahren zur herstellung von lactamen
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
DE59611017D1 (de) Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen
DE69414253D1 (de) Verfahren zur herstellung von oximin
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
ATE207900T1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
DE59401406D1 (de) Verfahren zur herstellung von naphtalocyaninen
DE69615836T2 (de) Verfahren zur herstellung von boroxyd
ATE181916T1 (de) Verfahren zur herstellung von hiv protease inhibitor ausgehend von (2s)-4-picolyl-2- piperazin-t-butylcarboxamid
DE59404478D1 (de) Verfahren zur herstellung von polyvinylpyridin-n-oxiden
ATA106595A (de) Verfahren zur herstellung von mmc-bauteilen
DE69602591T2 (de) Verfahren zur herstellung von hochalkalischen waschmitteltabletten
DE69418472D1 (de) Verfahren zur herstellung von goethit
DE69414000D1 (de) Verfahren zur herstellung von michael-additionsprodukten
DE69411012D1 (de) Verfahren zur herstellung von cumenhydroperoxyd

Legal Events

Date Code Title Description
8332 No legal effect for de